Biodegradation Rate of Embolized Protein Microspheres in Lung, Liver and Kidney of Rats
- 1 July 1989
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 41 (7) , 433-438
- https://doi.org/10.1111/j.2042-7158.1989.tb06496.x
Abstract
The targeting and sustained release characteristics of cytotoxic drug-loaded protein microspheres may prove useful in the therapeutic chemoembolization of solid tumours. Because biodegradation rate of embolized particles will influence rate of incorporated drug release and duration of exposure, this parameter was studied for microspheres (10–30 μm mean diam.) prepared from the proteins albumin and casein, that we have previously used as carriers for doxorubicin. As a measure of microsphere loss in-vivo the radionuclide 125I was chosen because it can be covalently bound to proteins and also homogeneously distributed throughout the matrix. Radiolabelled microspheres were administered to rats both intravenously (lung as target organ, 1·4-2·2 mg/100 g) and via the hepatic artery (liver as target organ, 0·4-0·8 mg/100 g). In both cases it was observed that the casein system biodegraded more slowly than the albumin in-vivo. Thus, time taken for loss of 50% of embolized microspheres from lung was: albumin 2·0 days; casein 3·5 days and from liver: albumin 3·6 days; casein 6·8 days. Microsphere “debris” did not markedly accumulate in other organs. In-vitro experiments showed that microspheres were stable in serum and that albumin microspheres were not innately more sensitive to enzymic digestion than casein. The results may be useful in estimating duration of exposure of target organs to drug-loaded microsphere systems prepared from these proteins.This publication has 23 references indexed in Scilit:
- Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastasesNuclear Medicine Communications, 1987
- Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model.Gut, 1987
- Chemoembolisation in regional cancer chemotherapy: a rationaleCancer Treatment Reviews, 1987
- Stopping bleeding by embolisation.BMJ, 1987
- The influence of degradable starch microspheres on liver uptake of 5-fluorouracil after hepatic artery injection in the ratJournal of Pharmacy and Pharmacology, 1986
- Intra-arterial infusion of doxorubicin with degradable starch microspheres. Improvement of hepatic tumor drug uptakeArchives of Surgery, 1986
- Hydrogels in endovascular embolization. II. Clinical use of spherical particlesBiomaterials, 1986
- Pulmonary reaction to intravenously injected polymer beadsJournal of Biomedical Materials Research, 1986
- Phase II Study of Hepatic Arterial Degradable Starch Microspheres and MitomycinCancer Drug Delivery, 1986
- Adriamycin‐loaded albumin microspheres: Preparation, in vivo distribution and release in the ratBiopharmaceutics & Drug Disposition, 1985